Home » Newsletters » BioWorld Asia

BioWorld Asia

July 19, 2000

View Archived Issues

Drugs For Sleep Disorders Could Follow Circadian Rhythm Finding

Zeltia Share Issue Brings In $172M On Madrid Exchange

EU Commissioners Determined To Resolve Biotech Standstill

Alizyme Plans To Raise #21M Through Public, Private Means

Other News To Note

Genomatix Completes First Pass At Promoter Sequence Analysis

French Government Launches Fund To Help Biotech Start-Ups

KS Biomedix Taking Sheep Antibody Into Human Trials

Transgene Selects 2 HGS Genes For Cardiovascular Applications

RiboTargets Gets Boost With #6M Second-Round Financing

Xenova Raises #10M In Units Offering In 'Improving' Market

French Government Confirms Its Stand On Gene Patenting

Challenges Pending For New Biotechnology Patent Rules

Biovector Plans To Move Flu Vaccine Into Phase III Trials

IBT Forced To Restructure Due To Shareholder Pressure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...